NCT03170960 · Interventional trial
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Overall registry status Active not recruiting
Phase 1
Conditions Castration-resistant Prostate Cancer, Colorectal Cancer, Differentiated Thyroid Cancer, Endometrial Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Head and Neck Cancer, Hepatocellular Carcinoma, Lower Esophageal Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Renal Cell Carcinoma, Triple Negative Breast Cancer, Urothelial Carcinoma
Delaware Valley sites
- Exelixis Clinical Site #15 · Philadelphia, PA · Philadelphia County
- Exelixis Clinical Site #38 · Camden, NJ · Camden County
- Exelixis Clinical Site #55 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory